121 related articles for article (PubMed ID: 11783141)
1. [Study on relationship between two different syndromes and three soluble cytokine receptors in patients with rheumatoid arthritis].
Hu Z; Hong J; Gao M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Dec; 19(12):718-20. PubMed ID: 11783141
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
4. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
Franke S; Herrmann D; Hein G; Müller A; Stein G
Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
[TBL] [Abstract][Full Text] [Related]
7. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
Lis AD; Brzezińska-Wcisło LA
Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
[TBL] [Abstract][Full Text] [Related]
8. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
9. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(2):130-4. PubMed ID: 2313471
[TBL] [Abstract][Full Text] [Related]
11. Similar serum levels of IL-6 and its soluble receptors in patients with HCV-related arthritis and rheumatoid arthritis: a pilot study.
Riccio A; Postiglione L; Sabatini P; Linvelli M; Soriente I; Sangiolo MG; Amato P; Tarantino G
Int J Immunopathol Pharmacol; 2012; 25(1):281-5. PubMed ID: 22507342
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.
Suenaga Y; Yasuda M; Yamamoto M; Nonaka S; Wada T; Shiokawa S; Nobunaga M
Clin Rheumatol; 1998; 17(4):311-7. PubMed ID: 9776115
[TBL] [Abstract][Full Text] [Related]
14. [Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis].
Herzog C; Herzog A; Aeschlimann A; Gerber H; Müller W
Z Rheumatol; 1990; 49(1):8-10. PubMed ID: 2327181
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin 2 receptor levels and radiological progression in early rheumatoid arthritis.
Camilleri JP; Amos N; Williams BD; Emery P; Williams LA; Jessop JD
J Rheumatol; 2001 Dec; 28(12):2576-8. PubMed ID: 11764199
[TBL] [Abstract][Full Text] [Related]
16. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
[TBL] [Abstract][Full Text] [Related]
17. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
19. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]